CN104232503B - A strain of Bacillus shachei and its application - Google Patents
A strain of Bacillus shachei and its application Download PDFInfo
- Publication number
- CN104232503B CN104232503B CN201410160307.8A CN201410160307A CN104232503B CN 104232503 B CN104232503 B CN 104232503B CN 201410160307 A CN201410160307 A CN 201410160307A CN 104232503 B CN104232503 B CN 104232503B
- Authority
- CN
- China
- Prior art keywords
- acid
- bacillus
- hna
- strain
- range
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 241000193830 Bacillus <bacterium> Species 0.000 title description 18
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims abstract description 24
- 241001304324 Bacillus shacheensis Species 0.000 claims abstract description 16
- 239000011780 sodium chloride Substances 0.000 claims abstract description 12
- 108010010803 Gelatin Proteins 0.000 claims abstract description 11
- 229920000159 gelatin Polymers 0.000 claims abstract description 11
- 239000008273 gelatin Substances 0.000 claims abstract description 11
- 235000019322 gelatine Nutrition 0.000 claims abstract description 11
- 235000011852 gelatine desserts Nutrition 0.000 claims abstract description 11
- 229920002472 Starch Polymers 0.000 claims abstract description 7
- 239000008107 starch Substances 0.000 claims abstract description 7
- 235000019698 starch Nutrition 0.000 claims abstract description 7
- CKLJMWTZIZZHCS-UWTATZPHSA-N D-aspartic acid Chemical compound OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 claims description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 9
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 9
- 229910052799 carbon Inorganic materials 0.000 claims description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 9
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 claims description 8
- -1 D-turranose Chemical compound 0.000 claims description 8
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims description 7
- WQZGKKKJIJFFOK-SVZMEOIVSA-N (+)-Galactose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 claims description 6
- GMKMEZVLHJARHF-UHFFFAOYSA-N (2R,6R)-form-2.6-Diaminoheptanedioic acid Natural products OC(=O)C(N)CCCC(N)C(O)=O GMKMEZVLHJARHF-UHFFFAOYSA-N 0.000 claims description 6
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims description 6
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims description 6
- AFENDNXGAFYKQO-UHFFFAOYSA-N 2-hydroxybutyric acid Chemical compound CCC(O)C(O)=O AFENDNXGAFYKQO-UHFFFAOYSA-N 0.000 claims description 6
- KPGXRSRHYNQIFN-UHFFFAOYSA-N 2-oxoglutaric acid Chemical compound OC(=O)CCC(=O)C(O)=O KPGXRSRHYNQIFN-UHFFFAOYSA-N 0.000 claims description 6
- XQXPVVBIMDBYFF-UHFFFAOYSA-N 4-hydroxyphenylacetic acid Chemical compound OC(=O)CC1=CC=C(O)C=C1 XQXPVVBIMDBYFF-UHFFFAOYSA-N 0.000 claims description 6
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 6
- MTCFGRXMJLQNBG-UWTATZPHSA-N D-Serine Chemical compound OC[C@@H](N)C(O)=O MTCFGRXMJLQNBG-UWTATZPHSA-N 0.000 claims description 6
- 229930195711 D-Serine Natural products 0.000 claims description 6
- JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 claims description 6
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 claims description 6
- JVTAAEKCZFNVCJ-REOHCLBHSA-N L-lactic acid Chemical compound C[C@H](O)C(O)=O JVTAAEKCZFNVCJ-REOHCLBHSA-N 0.000 claims description 6
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims description 6
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims description 6
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 claims description 6
- 235000011090 malic acid Nutrition 0.000 claims description 6
- GMKMEZVLHJARHF-SYDPRGILSA-N meso-2,6-diaminopimelic acid Chemical compound [O-]C(=O)[C@@H]([NH3+])CCC[C@@H]([NH3+])C([O-])=O GMKMEZVLHJARHF-SYDPRGILSA-N 0.000 claims description 6
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 6
- 150000008104 phosphatidylethanolamines Chemical class 0.000 claims description 6
- 150000003905 phosphatidylinositols Chemical class 0.000 claims description 6
- 238000012360 testing method Methods 0.000 claims description 6
- WHBMMWSBFZVSSR-UHFFFAOYSA-N 3-hydroxybutyric acid Chemical compound CC(O)CC(O)=O WHBMMWSBFZVSSR-UHFFFAOYSA-N 0.000 claims description 5
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 claims description 5
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 claims description 5
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 claims description 5
- 210000004027 cell Anatomy 0.000 claims description 5
- FRKBLBQTSTUKOV-UHFFFAOYSA-N diphosphatidyl glycerol Natural products OP(O)(=O)OCC(OP(O)(O)=O)COP(O)(O)=O FRKBLBQTSTUKOV-UHFFFAOYSA-N 0.000 claims description 5
- 229960002429 proline Drugs 0.000 claims description 5
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 4
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 4
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 4
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 4
- 229960005261 aspartic acid Drugs 0.000 claims description 4
- 229940014259 gelatin Drugs 0.000 claims description 4
- 229960002989 glutamic acid Drugs 0.000 claims description 4
- 235000011187 glycerol Nutrition 0.000 claims description 4
- 229960002885 histidine Drugs 0.000 claims description 4
- 150000002632 lipids Chemical class 0.000 claims description 4
- 229960002920 sorbitol Drugs 0.000 claims description 4
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 claims description 3
- AAWZDTNXLSGCEK-LNVDRNJUSA-N (3r,5r)-1,3,4,5-tetrahydroxycyclohexane-1-carboxylic acid Chemical compound O[C@@H]1CC(O)(C(O)=O)C[C@@H](O)C1O AAWZDTNXLSGCEK-LNVDRNJUSA-N 0.000 claims description 3
- BJEPYKJPYRNKOW-UWTATZPHSA-N (R)-malic acid Chemical compound OC(=O)[C@H](O)CC(O)=O BJEPYKJPYRNKOW-UWTATZPHSA-N 0.000 claims description 3
- XKLJLHAPJBUBNL-UHFFFAOYSA-N 12-methyltetradecanoic acid Chemical compound CCC(C)CCCCCCCCCCC(O)=O XKLJLHAPJBUBNL-UHFFFAOYSA-N 0.000 claims description 3
- TYEYBOSBBBHJIV-UHFFFAOYSA-N 2-oxobutanoic acid Chemical compound CCC(=O)C(O)=O TYEYBOSBBBHJIV-UHFFFAOYSA-N 0.000 claims description 3
- RMTFNDVZYPHUEF-XZBKPIIZSA-N 3-O-methyl-D-glucose Chemical compound O=C[C@H](O)[C@@H](OC)[C@H](O)[C@H](O)CO RMTFNDVZYPHUEF-XZBKPIIZSA-N 0.000 claims description 3
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 3
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 claims description 3
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 claims description 3
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 3
- WZPBZJONDBGPKJ-UHFFFAOYSA-N Antibiotic SQ 26917 Natural products O=C1N(S(O)(=O)=O)C(C)C1NC(=O)C(=NOC(C)(C)C(O)=O)C1=CSC(N)=N1 WZPBZJONDBGPKJ-UHFFFAOYSA-N 0.000 claims description 3
- 102000016938 Catalase Human genes 0.000 claims description 3
- 108010053835 Catalase Proteins 0.000 claims description 3
- AAWZDTNXLSGCEK-UHFFFAOYSA-N Cordycepinsaeure Natural products OC1CC(O)(C(O)=O)CC(O)C1O AAWZDTNXLSGCEK-UHFFFAOYSA-N 0.000 claims description 3
- GUBGYTABKSRVRQ-UHFFFAOYSA-N D-Cellobiose Natural products OCC1OC(OC2C(O)C(O)C(O)OC2CO)C(O)C(O)C1O GUBGYTABKSRVRQ-UHFFFAOYSA-N 0.000 claims description 3
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 claims description 3
- GSXOAOHZAIYLCY-UHFFFAOYSA-N D-F6P Natural products OCC(=O)C(O)C(O)C(O)COP(O)(O)=O GSXOAOHZAIYLCY-UHFFFAOYSA-N 0.000 claims description 3
- RFSUNEUAIZKAJO-VRPWFDPXSA-N D-Fructose Natural products OC[C@H]1OC(O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-VRPWFDPXSA-N 0.000 claims description 3
- NBSCHQHZLSJFNQ-GASJEMHNSA-N D-Glucose 6-phosphate Chemical compound OC1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@H]1O NBSCHQHZLSJFNQ-GASJEMHNSA-N 0.000 claims description 3
- 229930182843 D-Lactic acid Natural products 0.000 claims description 3
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 claims description 3
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 claims description 3
- HEBKCHPVOIAQTA-QWWZWVQMSA-N D-arabinitol Chemical compound OC[C@@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-QWWZWVQMSA-N 0.000 claims description 3
- DSLZVSRJTYRBFB-LLEIAEIESA-N D-glucaric acid Chemical compound OC(=O)[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O DSLZVSRJTYRBFB-LLEIAEIESA-N 0.000 claims description 3
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 claims description 3
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 claims description 3
- JVTAAEKCZFNVCJ-UWTATZPHSA-N D-lactic acid Chemical compound C[C@@H](O)C(O)=O JVTAAEKCZFNVCJ-UWTATZPHSA-N 0.000 claims description 3
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 claims description 3
- 229920001353 Dextrin Polymers 0.000 claims description 3
- 239000004375 Dextrin Substances 0.000 claims description 3
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 3
- IECPWNUMDGFDKC-UHFFFAOYSA-N Fusicsaeure Natural products C12C(O)CC3C(=C(CCC=C(C)C)C(O)=O)C(OC(C)=O)CC3(C)C1(C)CCC1C2(C)CCC(O)C1C IECPWNUMDGFDKC-UHFFFAOYSA-N 0.000 claims description 3
- DSLZVSRJTYRBFB-UHFFFAOYSA-N Galactaric acid Natural products OC(=O)C(O)C(O)C(O)C(O)C(O)=O DSLZVSRJTYRBFB-UHFFFAOYSA-N 0.000 claims description 3
- VFRROHXSMXFLSN-UHFFFAOYSA-N Glc6P Natural products OP(=O)(O)OCC(O)C(O)C(O)C(O)C=O VFRROHXSMXFLSN-UHFFFAOYSA-N 0.000 claims description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 3
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 claims description 3
- QNAYBMKLOCPYGJ-UWTATZPHSA-N L-Alanine Natural products C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 claims description 3
- SHZGCJCMOBCMKK-PQMKYFCFSA-N L-Fucose Natural products C[C@H]1O[C@H](O)[C@@H](O)[C@@H](O)[C@@H]1O SHZGCJCMOBCMKK-PQMKYFCFSA-N 0.000 claims description 3
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 3
- 229930064664 L-arginine Natural products 0.000 claims description 3
- 235000014852 L-arginine Nutrition 0.000 claims description 3
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 claims description 3
- OJMMVQQUTAEWLP-UHFFFAOYSA-N Lincomycin Natural products CN1CC(CCC)CC1C(=O)NC(C(C)O)C1C(O)C(O)C(O)C(SC)O1 OJMMVQQUTAEWLP-UHFFFAOYSA-N 0.000 claims description 3
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 3
- MSFSPUZXLOGKHJ-UHFFFAOYSA-N Muraminsaeure Natural products OC(=O)C(C)OC1C(N)C(O)OC(CO)C1O MSFSPUZXLOGKHJ-UHFFFAOYSA-N 0.000 claims description 3
- OVRNDRQMDRJTHS-CBQIKETKSA-N N-Acetyl-D-Galactosamine Chemical compound CC(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@H](O)[C@@H]1O OVRNDRQMDRJTHS-CBQIKETKSA-N 0.000 claims description 3
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 claims description 3
- MBLBDJOUHNCFQT-UHFFFAOYSA-N N-acetyl-D-galactosamine Natural products CC(=O)NC(C=O)C(O)C(O)C(O)CO MBLBDJOUHNCFQT-UHFFFAOYSA-N 0.000 claims description 3
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 claims description 3
- SQVRNKJHWKZAKO-PFQGKNLYSA-N N-acetyl-beta-neuraminic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)O[C@H]1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-PFQGKNLYSA-N 0.000 claims description 3
- DKXNBNKWCZZMJT-UHFFFAOYSA-N O4-alpha-D-Mannopyranosyl-D-mannose Natural products O=CC(O)C(O)C(C(O)CO)OC1OC(CO)C(O)C(O)C1O DKXNBNKWCZZMJT-UHFFFAOYSA-N 0.000 claims description 3
- AYRXSINWFIIFAE-UHFFFAOYSA-N O6-alpha-D-Galactopyranosyl-D-galactose Natural products OCC1OC(OCC(O)C(O)C(O)C(O)C=O)C(O)C(O)C1O AYRXSINWFIIFAE-UHFFFAOYSA-N 0.000 claims description 3
- 102000004316 Oxidoreductases Human genes 0.000 claims description 3
- 108090000854 Oxidoreductases Proteins 0.000 claims description 3
- 108010013639 Peptidoglycan Proteins 0.000 claims description 3
- AAWZDTNXLSGCEK-ZHQZDSKASA-N Quinic acid Natural products O[C@H]1CC(O)(C(O)=O)C[C@H](O)C1O AAWZDTNXLSGCEK-ZHQZDSKASA-N 0.000 claims description 3
- 229930189077 Rifamycin Natural products 0.000 claims description 3
- UQZIYBXSHAGNOE-USOSMYMVSA-N Stachyose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO[C@@H]2[C@@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O2)O1 UQZIYBXSHAGNOE-USOSMYMVSA-N 0.000 claims description 3
- 229930006000 Sucrose Natural products 0.000 claims description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 3
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 claims description 3
- 108010059993 Vancomycin Proteins 0.000 claims description 3
- ODHCTXKNWHHXJC-UHFFFAOYSA-N acide pyroglutamique Natural products OC(=O)C1CCC(=O)N1 ODHCTXKNWHHXJC-UHFFFAOYSA-N 0.000 claims description 3
- 229960003767 alanine Drugs 0.000 claims description 3
- WQZGKKKJIJFFOK-DVKNGEFBSA-N alpha-D-glucose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-DVKNGEFBSA-N 0.000 claims description 3
- AEMOLEFTQBMNLQ-WAXACMCWSA-N alpha-D-glucuronic acid Chemical compound O[C@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-WAXACMCWSA-N 0.000 claims description 3
- 229940024606 amino acid Drugs 0.000 claims description 3
- 235000001014 amino acid Nutrition 0.000 claims description 3
- WZPBZJONDBGPKJ-VEHQQRBSSA-N aztreonam Chemical compound O=C1N(S([O-])(=O)=O)[C@@H](C)[C@@H]1NC(=O)C(=N/OC(C)(C)C(O)=O)\C1=CSC([NH3+])=N1 WZPBZJONDBGPKJ-VEHQQRBSSA-N 0.000 claims description 3
- 229960003644 aztreonam Drugs 0.000 claims description 3
- SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 claims description 3
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 claims description 3
- QQWGVQWAEANRTK-UHFFFAOYSA-N bromosuccinic acid Chemical compound OC(=O)CC(Br)C(O)=O QQWGVQWAEANRTK-UHFFFAOYSA-N 0.000 claims description 3
- 210000002421 cell wall Anatomy 0.000 claims description 3
- 239000001913 cellulose Substances 0.000 claims description 3
- 229920002678 cellulose Polymers 0.000 claims description 3
- 229940022769 d- lactic acid Drugs 0.000 claims description 3
- 235000019425 dextrin Nutrition 0.000 claims description 3
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 3
- 229930195729 fatty acid Natural products 0.000 claims description 3
- 239000000194 fatty acid Substances 0.000 claims description 3
- 150000004665 fatty acids Chemical class 0.000 claims description 3
- 235000019253 formic acid Nutrition 0.000 claims description 3
- 229960004675 fusidic acid Drugs 0.000 claims description 3
- IECPWNUMDGFDKC-MZJAQBGESA-N fusidic acid Chemical compound O[C@@H]([C@@H]12)C[C@H]3\C(=C(/CCC=C(C)C)C(O)=O)[C@@H](OC(C)=O)C[C@]3(C)[C@@]2(C)CC[C@@H]2[C@]1(C)CC[C@@H](O)[C@H]2C IECPWNUMDGFDKC-MZJAQBGESA-N 0.000 claims description 3
- DSLZVSRJTYRBFB-DUHBMQHGSA-N galactaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(O)=O DSLZVSRJTYRBFB-DUHBMQHGSA-N 0.000 claims description 3
- 229960003692 gamma aminobutyric acid Drugs 0.000 claims description 3
- DLRVVLDZNNYCBX-CQUJWQHSSA-N gentiobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-CQUJWQHSSA-N 0.000 claims description 3
- 235000012208 gluconic acid Nutrition 0.000 claims description 3
- 229950006191 gluconic acid Drugs 0.000 claims description 3
- 229960000789 guanidine hydrochloride Drugs 0.000 claims description 3
- PJJJBBJSCAKJQF-UHFFFAOYSA-N guanidinium chloride Chemical compound [Cl-].NC(N)=[NH2+] PJJJBBJSCAKJQF-UHFFFAOYSA-N 0.000 claims description 3
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 claims description 3
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 claims description 3
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims description 3
- 229960000367 inositol Drugs 0.000 claims description 3
- GSXOAOHZAIYLCY-HSUXUTPPSA-N keto-D-fructose 6-phosphate Chemical compound OCC(=O)[C@@H](O)[C@H](O)[C@H](O)COP(O)(O)=O GSXOAOHZAIYLCY-HSUXUTPPSA-N 0.000 claims description 3
- 229940116298 l- malic acid Drugs 0.000 claims description 3
- 229960005287 lincomycin Drugs 0.000 claims description 3
- OJMMVQQUTAEWLP-KIDUDLJLSA-N lincomycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@@H](C)O)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 OJMMVQQUTAEWLP-KIDUDLJLSA-N 0.000 claims description 3
- FUJCRWPEOMXPAD-UHFFFAOYSA-N lithium oxide Chemical compound [Li+].[Li+].[O-2] FUJCRWPEOMXPAD-UHFFFAOYSA-N 0.000 claims description 3
- 229910001947 lithium oxide Inorganic materials 0.000 claims description 3
- 229960002160 maltose Drugs 0.000 claims description 3
- 235000010355 mannitol Nutrition 0.000 claims description 3
- DLRVVLDZNNYCBX-ABXHMFFYSA-N melibiose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-ABXHMFFYSA-N 0.000 claims description 3
- 239000011700 menaquinone-7 Substances 0.000 claims description 3
- HOVAGTYPODGVJG-XUUWZHRGSA-N methyl beta-D-glucopyranoside Chemical compound CO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HOVAGTYPODGVJG-XUUWZHRGSA-N 0.000 claims description 3
- CWKLZLBVOJRSOM-UHFFFAOYSA-N methyl pyruvate Chemical compound COC(=O)C(C)=O CWKLZLBVOJRSOM-UHFFFAOYSA-N 0.000 claims description 3
- 229960004023 minocycline Drugs 0.000 claims description 3
- DYKFCLLONBREIL-KVUCHLLUSA-N minocycline Chemical compound C([C@H]1C2)C3=C(N(C)C)C=CC(O)=C3C(=O)C1=C(O)[C@@]1(O)[C@@H]2[C@H](N(C)C)C(O)=C(C(N)=O)C1=O DYKFCLLONBREIL-KVUCHLLUSA-N 0.000 claims description 3
- 229950006780 n-acetylglucosamine Drugs 0.000 claims description 3
- MHWLWQUZZRMNGJ-UHFFFAOYSA-N nalidixic acid Chemical compound C1=C(C)N=C2N(CC)C=C(C(O)=O)C(=O)C2=C1 MHWLWQUZZRMNGJ-UHFFFAOYSA-N 0.000 claims description 3
- 229960000210 nalidixic acid Drugs 0.000 claims description 3
- 239000001814 pectin Substances 0.000 claims description 3
- 235000010987 pectin Nutrition 0.000 claims description 3
- 229960000292 pectin Drugs 0.000 claims description 3
- 229920001277 pectin Polymers 0.000 claims description 3
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 3
- 229920000053 polysorbate 80 Polymers 0.000 claims description 3
- BFPJYWDBBLZXOM-UHFFFAOYSA-L potassium tellurite Chemical compound [K+].[K+].[O-][Te]([O-])=O BFPJYWDBBLZXOM-UHFFFAOYSA-L 0.000 claims description 3
- 235000019260 propionic acid Nutrition 0.000 claims description 3
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 claims description 3
- 229960003292 rifamycin Drugs 0.000 claims description 3
- HJYYPODYNSCCOU-ODRIEIDWSA-N rifamycin SV Chemical compound OC1=C(C(O)=C2C)C3=C(O)C=C1NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H](C)[C@@H](OC)\C=C\O[C@@]1(C)OC2=C3C1=O HJYYPODYNSCCOU-ODRIEIDWSA-N 0.000 claims description 3
- NGFMICBWJRZIBI-UJPOAAIJSA-N salicin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=CC=C1CO NGFMICBWJRZIBI-UJPOAAIJSA-N 0.000 claims description 3
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims description 3
- 229960001153 serine Drugs 0.000 claims description 3
- XUXNAKZDHHEHPC-UHFFFAOYSA-M sodium bromate Chemical compound [Na+].[O-]Br(=O)=O XUXNAKZDHHEHPC-UHFFFAOYSA-M 0.000 claims description 3
- 239000001540 sodium lactate Substances 0.000 claims description 3
- 235000011088 sodium lactate Nutrition 0.000 claims description 3
- 229940005581 sodium lactate Drugs 0.000 claims description 3
- URLJMZWTXZTZRR-UHFFFAOYSA-N sodium myristyl sulfate Chemical compound CCCCCCCCCCCCCCOS(O)(=O)=O URLJMZWTXZTZRR-UHFFFAOYSA-N 0.000 claims description 3
- UQZIYBXSHAGNOE-XNSRJBNMSA-N stachyose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)O2)O)O1 UQZIYBXSHAGNOE-XNSRJBNMSA-N 0.000 claims description 3
- 239000005720 sucrose Substances 0.000 claims description 3
- MUUHXGOJWVMBDY-UHFFFAOYSA-L tetrazolium blue Chemical compound [Cl-].[Cl-].COC1=CC(C=2C=C(OC)C(=CC=2)[N+]=2N(N=C(N=2)C=2C=CC=CC=2)C=2C=CC=CC=2)=CC=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=CC=C1 MUUHXGOJWVMBDY-UHFFFAOYSA-L 0.000 claims description 3
- RONADMZTCCPLEF-UHFFFAOYSA-M tetrazolium violet Chemical compound [Cl-].C1=CC=CC=C1C(N=[N+]1C=2C3=CC=CC=C3C=CC=2)=NN1C1=CC=CC=C1 RONADMZTCCPLEF-UHFFFAOYSA-M 0.000 claims description 3
- 229960005041 troleandomycin Drugs 0.000 claims description 3
- LQCLVBQBTUVCEQ-QTFUVMRISA-N troleandomycin Chemical compound O1[C@@H](C)[C@H](OC(C)=O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](C)C(=O)O[C@H](C)[C@H](C)[C@H](OC(C)=O)[C@@H](C)C(=O)[C@@]2(OC2)C[C@H](C)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)OC(C)=O)[C@H]1C LQCLVBQBTUVCEQ-QTFUVMRISA-N 0.000 claims description 3
- MYPYJXKWCTUITO-LYRMYLQWSA-N vancomycin Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)NC)[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-N 0.000 claims description 3
- 229960003165 vancomycin Drugs 0.000 claims description 3
- MYPYJXKWCTUITO-UHFFFAOYSA-N vancomycin Natural products O1C(C(=C2)Cl)=CC=C2C(O)C(C(NC(C2=CC(O)=CC(O)=C2C=2C(O)=CC=C3C=2)C(O)=O)=O)NC(=O)C3NC(=O)C2NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC)C(O)C(C=C3Cl)=CC=C3OC3=CC2=CC1=C3OC1OC(CO)C(O)C(O)C1OC1CC(C)(N)C(O)C(C)O1 MYPYJXKWCTUITO-UHFFFAOYSA-N 0.000 claims description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 claims 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 claims 1
- WDJHALXBUFZDSR-UHFFFAOYSA-M acetoacetate Chemical compound CC(=O)CC([O-])=O WDJHALXBUFZDSR-UHFFFAOYSA-M 0.000 claims 1
- 125000004383 glucosinolate group Chemical group 0.000 claims 1
- 229910017604 nitric acid Inorganic materials 0.000 claims 1
- 239000011435 rock Substances 0.000 claims 1
- MFBOGIVSZKQAPD-UHFFFAOYSA-M sodium butyrate Chemical compound [Na+].CCCC([O-])=O MFBOGIVSZKQAPD-UHFFFAOYSA-M 0.000 claims 1
- 241000894006 Bacteria Species 0.000 abstract description 20
- 150000003839 salts Chemical class 0.000 abstract description 16
- 102000004190 Enzymes Human genes 0.000 abstract description 8
- 108090000790 Enzymes Proteins 0.000 abstract description 8
- 230000000694 effects Effects 0.000 abstract description 5
- 238000004519 manufacturing process Methods 0.000 abstract description 4
- 238000004321 preservation Methods 0.000 abstract description 4
- 238000012216 screening Methods 0.000 abstract description 4
- GZCWLCBFPRFLKL-UHFFFAOYSA-N 1-prop-2-ynoxypropan-2-ol Chemical compound CC(O)COCC#C GZCWLCBFPRFLKL-UHFFFAOYSA-N 0.000 abstract description 3
- 108010051457 Acid Phosphatase Proteins 0.000 abstract description 3
- 102000013563 Acid Phosphatase Human genes 0.000 abstract description 3
- 108090000371 Esterases Proteins 0.000 abstract description 3
- 108090001060 Lipase Proteins 0.000 abstract description 3
- 238000002955 isolation Methods 0.000 abstract description 3
- 239000002689 soil Substances 0.000 abstract description 3
- 239000003513 alkali Substances 0.000 abstract description 2
- 229930000044 secondary metabolite Natural products 0.000 abstract 1
- 239000002609 medium Substances 0.000 description 20
- 238000000034 method Methods 0.000 description 10
- 108020004465 16S ribosomal RNA Proteins 0.000 description 9
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 8
- 229940088598 enzyme Drugs 0.000 description 7
- 238000004458 analytical method Methods 0.000 description 6
- 239000011259 mixed solution Substances 0.000 description 6
- 235000013336 milk Nutrition 0.000 description 5
- 239000008267 milk Substances 0.000 description 5
- 210000004080 milk Anatomy 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 241000894007 species Species 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 230000001580 bacterial effect Effects 0.000 description 4
- 238000005345 coagulation Methods 0.000 description 4
- 230000015271 coagulation Effects 0.000 description 4
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000008223 sterile water Substances 0.000 description 4
- QJZYHAIUNVAGQP-UHFFFAOYSA-N 3-nitrobicyclo[2.2.1]hept-5-ene-2,3-dicarboxylic acid Chemical compound C1C2C=CC1C(C(=O)O)C2(C(O)=O)[N+]([O-])=O QJZYHAIUNVAGQP-UHFFFAOYSA-N 0.000 description 3
- 241001328122 Bacillus clausii Species 0.000 description 3
- 108020004414 DNA Proteins 0.000 description 3
- 244000068988 Glycine max Species 0.000 description 3
- 235000010469 Glycine max Nutrition 0.000 description 3
- 229940041514 candida albicans extract Drugs 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- 238000000855 fermentation Methods 0.000 description 3
- 230000004151 fermentation Effects 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 238000010353 genetic engineering Methods 0.000 description 3
- 239000004021 humic acid Substances 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 108010009004 proteose-peptone Proteins 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 238000012163 sequencing technique Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000012138 yeast extract Substances 0.000 description 3
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- KIIBBJKLKFTNQO-WHFBIAKZSA-N 5-hydroxyectoine Chemical compound CC1=N[C@H](C(O)=O)[C@@H](O)CN1 KIIBBJKLKFTNQO-WHFBIAKZSA-N 0.000 description 2
- WDJHALXBUFZDSR-UHFFFAOYSA-N Acetoacetic acid Natural products CC(=O)CC(O)=O WDJHALXBUFZDSR-UHFFFAOYSA-N 0.000 description 2
- 239000004382 Amylase Substances 0.000 description 2
- 102000013142 Amylases Human genes 0.000 description 2
- 108010065511 Amylases Proteins 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- AEMOLEFTQBMNLQ-DTEWXJGMSA-N D-Galacturonic acid Natural products O[C@@H]1O[C@H](C(O)=O)[C@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-DTEWXJGMSA-N 0.000 description 2
- SHZGCJCMOBCMKK-SVZMEOIVSA-N D-fucopyranose Chemical compound C[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O SHZGCJCMOBCMKK-SVZMEOIVSA-N 0.000 description 2
- WQXNXVUDBPYKBA-UHFFFAOYSA-N Ectoine Natural products CC1=NCCC(C(O)=O)N1 WQXNXVUDBPYKBA-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 2
- 238000007476 Maximum Likelihood Methods 0.000 description 2
- OVRNDRQMDRJTHS-OZRXBMAMSA-N N-acetyl-beta-D-mannosamine Chemical compound CC(=O)N[C@@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-OZRXBMAMSA-N 0.000 description 2
- 229910002651 NO3 Inorganic materials 0.000 description 2
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 2
- IAJILQKETJEXLJ-RSJOWCBRSA-N aldehydo-D-galacturonic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-RSJOWCBRSA-N 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 235000019418 amylase Nutrition 0.000 description 2
- AEMOLEFTQBMNLQ-UHFFFAOYSA-N beta-D-galactopyranuronic acid Natural products OC1OC(C(O)=O)C(O)C(O)C1O AEMOLEFTQBMNLQ-UHFFFAOYSA-N 0.000 description 2
- VOIFKEWOFUNPBN-QIUUJYRFSA-N beta-D-glucuronamide Chemical compound NC(=O)[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O VOIFKEWOFUNPBN-QIUUJYRFSA-N 0.000 description 2
- 229960003237 betaine Drugs 0.000 description 2
- SWEYNHYBJHPVJL-UHFFFAOYSA-N butanoic acid;sodium Chemical compound [Na].CCCC(O)=O SWEYNHYBJHPVJL-UHFFFAOYSA-N 0.000 description 2
- WOWBFOBYOAGEEA-UHFFFAOYSA-N diafenthiuron Chemical compound CC(C)C1=C(NC(=S)NC(C)(C)C)C(C(C)C)=CC(OC=2C=CC=CC=2)=C1 WOWBFOBYOAGEEA-UHFFFAOYSA-N 0.000 description 2
- WQXNXVUDBPYKBA-YFKPBYRVSA-N ectoine Chemical compound CC1=[NH+][C@H](C([O-])=O)CCN1 WQXNXVUDBPYKBA-YFKPBYRVSA-N 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 229950004542 glucuronamide Drugs 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- ZOCYQVNGROEVLU-UHFFFAOYSA-N isopentadecanoic acid Chemical compound CC(C)CCCCCCCCCCCC(O)=O ZOCYQVNGROEVLU-UHFFFAOYSA-N 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 2
- 235000015067 sauces Nutrition 0.000 description 2
- 235000015393 sodium molybdate Nutrition 0.000 description 2
- 239000011684 sodium molybdate Substances 0.000 description 2
- TVXXNOYZHKPKGW-UHFFFAOYSA-N sodium molybdate (anhydrous) Chemical compound [Na+].[Na+].[O-][Mo]([O-])(=O)=O TVXXNOYZHKPKGW-UHFFFAOYSA-N 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 239000012137 tryptone Substances 0.000 description 2
- RULSWEULPANCDV-PIXUTMIVSA-N turanose Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](C(=O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O RULSWEULPANCDV-PIXUTMIVSA-N 0.000 description 2
- 239000004474 valine Substances 0.000 description 2
- JFGQHAHJWJBOPD-UHFFFAOYSA-N 3-hydroxy-n-phenylnaphthalene-2-carboxamide Chemical compound OC1=CC2=CC=CC=C2C=C1C(=O)NC1=CC=CC=C1 JFGQHAHJWJBOPD-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 241000186361 Actinobacteria <class> Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 241000025050 Bacillus rhizosphaerae Species 0.000 description 1
- 108020000946 Bacterial DNA Proteins 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 102000013382 Gelatinases Human genes 0.000 description 1
- 108010026132 Gelatinases Proteins 0.000 description 1
- 102000053187 Glucuronidase Human genes 0.000 description 1
- 108010060309 Glucuronidase Proteins 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 241001330505 Halomonas alimentaria Species 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 108010006519 Molecular Chaperones Proteins 0.000 description 1
- 102000005431 Molecular Chaperones Human genes 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 241000006383 Salimicrobium halophilum Species 0.000 description 1
- 244000062793 Sorghum vulgare Species 0.000 description 1
- 241000500332 Tetragenococcus halophilus Species 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 239000007956 bioemulsifier Substances 0.000 description 1
- 238000010170 biological method Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 229940079919 digestives enzyme preparation Drugs 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 235000021107 fermented food Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229940049906 glutamate Drugs 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 229960002449 glycine Drugs 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 125000001475 halogen functional group Chemical group 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 239000010842 industrial wastewater Substances 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 235000019713 millet Nutrition 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 238000011392 neighbor-joining method Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 238000004391 petroleum recovery Methods 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 235000021110 pickles Nutrition 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000012257 pre-denaturation Methods 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 235000014102 seafood Nutrition 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 230000036620 skin dryness Effects 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 235000021404 traditional food Nutrition 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
本发明公开了一种莎车芽孢杆菌Bacillus shacheensis HNA‑14,其在韩国典型菌种保藏中心的保藏编号是KCTC 33145。通过从新疆莎车县盐碱土分离、筛选、生理生化鉴定等工作,确定该菌株为短杆状(图一)革兰氏阳性菌,严格好氧,产芽孢,具有运动性,细胞大小为0.5‑0.8×1.0‑1.5μm,菌落呈黄色。NaCl耐受范围为3%‑20%(最佳盐浓度为7%‑15%),pH生长范围为6.5‑10.0(最佳pH范围为7.5‑8.0),温度生长范围为5‑40℃(最佳生长温度为25‑30℃)。本发明的新疆莎车嗜盐菌Bacillusshacheensis HNA‑14能有效分解明胶和淀粉,具有Esterase(C4)、Esterase lipase(C8)、Valinearylamidase、Acid phosphatase和Naphthol‑AS‑B1‑phosphohydrolase酶活性,同时该菌株具有较高的盐浓度适应性,能在较高的盐浓度下生存,该中度嗜盐菌可广泛地应用在次级代谢产物高盐浓度下的生产。附图是扫描电子显微镜10000倍下观察到的菌株HNA‑14的形貌。
The invention discloses a Bacillus shacheensis HNA‑14, whose preservation number in the Korean Type Culture Collection is KCTC 33145. Through isolation, screening, and physiological and biochemical identification from the saline-alkali soil in Shache County, Xinjiang, it was determined that the strain was a short rod-shaped (Figure 1) Gram-positive bacterium, strictly aerobic, spore-forming, motile, and the cell size was 0.5 ‑0.8×1.0‑1.5 μm, the colony is yellow. The NaCl tolerance range is 3%‑20% (the optimal salt concentration is 7%‑15%), the pH growth range is 6.5‑10.0 (the optimal pH range is 7.5‑8.0), and the temperature growth range is 5‑40°C ( The optimum growth temperature is 25-30°C). The Xinjiang Shache halophilic bacteria Bacillusshacheensis HNA‑14 of the present invention can effectively decompose gelatin and starch, has Esterase (C4), Esterase lipase (C8), Valinearylamidase, Acid phosphatase and Naphthol‑AS‑B1‑phosphohydrolase enzyme activities, and the strain It has high adaptability to salt concentration and can survive under high salt concentration. The moderately halophilic bacteria can be widely used in the production of secondary metabolites under high salt concentration. The accompanying drawing is the morphology of strain HNA‑14 observed under a scanning electron microscope at 10,000 times.
Description
技术领域technical field
本发明涉及微生物菌种及其应用领域,具体地说本发明涉及一种芽孢杆菌及其应用的技术领域。The invention relates to the field of microbial strains and applications thereof, in particular to the technical field of a bacillus and its applications.
背景技术Background technique
中度嗜盐菌并非分类学上的专业名词,而是对一类最佳耐盐浓度在3%-15%的极端微生物的统称。它广泛分布在各类高盐环境中,如海洋、盐湖、盐碱地、盐池这些自然环境及很多发酵食品中都能被发现。Moderate halophilic bacteria is not a taxonomic term, but a general term for a class of extremophiles whose best salt-tolerant concentration is between 3% and 15%. It is widely distributed in various high-salt environments, such as oceans, salt lakes, saline-alkali lands, salt ponds, and many fermented foods.
中度嗜盐菌因其独特的生长环境与耐盐机制,从而具有很多显著的特点:(1) 可在较高的盐浓度下生长,降低发酵过程中染菌风险;(2) 不需要较为复杂的营养条件,碳氮源利用范围广泛;(3) 生理生化特性多样,潜在应用价值巨大。Due to their unique growth environment and salt-tolerant mechanism, moderately halophilic bacteria have many notable features: (1) they can grow at higher salt concentrations, reducing the risk of bacterial contamination during fermentation; (2) they do not require comparison Complex nutritional conditions, a wide range of carbon and nitrogen sources; (3) diverse physiological and biochemical characteristics, and great potential application value.
近些年来,随着中度嗜盐菌研究的不断深入,越来越多的新种被发现,人们对它们所表现出来的潜在应用价值兴奋不已。现今,中度嗜盐菌的应用研究主要集中在以下几个方面:In recent years, with the continuous deepening of the research on moderate halophilic bacteria, more and more new species have been discovered, and people are excited about their potential application value. Nowadays, the applied research of moderate halophilic bacteria mainly focuses on the following aspects:
(1) 食品工业上的应用。传统的食品发酵工业中,嗜盐微生物的应用由来已久,如食品调味酱就是通过将小麦、谷子和大豆等农作物密封浸泡在19%左右的NaCl溶液中,经发酵9-10个月而成。科学家们发现,在此过程中,有一种名为Tetragenococcus halophilus的中度嗜盐菌起到了主要的发酵推动与承担作用,其高达108 CFU/mL的培养基细胞浓度不仅能抑制其他细菌生长,还能保证在混合氨基酸缺乏的环境下酱的风味浓郁不散而且美味可口。在韩国,人们经常喜欢将海产品进行腌制,而这过程中起到主要作用的菌株也是一类中度嗜盐菌,名为Halomonas alimentaria 。许多中度嗜盐菌的菌落也十分好看,多呈橙色或粉红色,而其中的有益品种亦被用来生产天然食品添加剂。(1) Application in food industry. In the traditional food fermentation industry, the application of halophilic microorganisms has a long history. For example, food seasoning sauce is made by sealing and soaking crops such as wheat, millet and soybeans in about 19% NaCl solution and fermenting them for 9-10 months. . The scientists found that during this process, a moderately halophilic bacterium called Tetragenococcus halophilus played a major role in promoting and undertaking the fermentation. Its concentration of 108 CFU/mL of medium cells not only inhibited the growth of other bacteria, but also inhibited the growth of other bacteria. It can ensure that the flavor of the sauce is strong and delicious under the environment of lack of mixed amino acids. In Korea, people often like to pickle seafood, and the strain that plays a major role in this process is also a type of moderate halophilic bacteria called Halomonas alimentaria . Colonies of many moderately halophilic bacteria are also very attractive, often orange or pink, and beneficial species of them are also used to produce natural food additives.
(2) 酶制剂生产上的应用。工业生产通常需要满足很多特殊的物化条件,然而却常常难以与酶反应所需的最佳条件相匹配,这就对酶的适应条件提供了更高的要求。中度嗜盐菌产生的酶恰恰具有广泛的盐度、温度耐受范围,还有容易纯化的优点,故而受到广泛关注,有着良好的商业应用前景。(2) Application in the production of enzyme preparations. Industrial production usually needs to meet many special physical and chemical conditions, but it is often difficult to match the optimal conditions required by the enzyme reaction, which provides higher requirements for the adaptation conditions of the enzyme. The enzymes produced by moderate halophilic bacteria have a wide range of salinity and temperature tolerance, and the advantages of easy purification, so they have attracted widespread attention and have good commercial application prospects.
(3) 基因工程和化妆品领域的应用。在高盐环境下,中度嗜盐菌常常可以积累许多相容性物质,如海藻糖,四氢嘧啶,甜菜碱,脯氨酸,羟基四氢嘧啶等。因其具有良好的渗透保护功能,受到分子基因工程与化妆品领域的广泛关注。其中,四氢嘧啶和羟基四氢嘧啶是一种被称为分子伴侣的稳定剂,它们具有在极端环境如高盐、高温、干燥或低温下稳定和保护生物大分子酶、DNA的作用。同时它们还具有防止皮肤干燥,减缓皮肤衰老的作用,是一种很好的化妆品保湿剂。(3) Applications in the fields of genetic engineering and cosmetics. In a high-salt environment, moderately halophilic bacteria can often accumulate many compatible substances, such as trehalose, ectoine, betaine, proline, hydroxyectoine, etc. Because of its good osmotic protection function, it has attracted extensive attention in the fields of molecular genetic engineering and cosmetics. Among them, ectoine and hydroxyectoine are stabilizers called molecular chaperones, which have the function of stabilizing and protecting biological macromolecular enzymes and DNA in extreme environments such as high salt, high temperature, dryness or low temperature. At the same time, they also have the effect of preventing skin dryness and slowing down skin aging, and are a good cosmetic moisturizer.
(4) 多聚体生产方面的应用。石油沉积后往往会形成较高的盐浓度,一般的表面活性剂与生物乳化剂常常难以适应,这为石油的回收利用增加了难度。中度嗜盐菌形成的胞外多聚体无疑具有显著优势。(4) Applications in polymer production. After petroleum deposits, high salt concentration is often formed, and general surfactants and bio-emulsifiers are often difficult to adapt to, which increases the difficulty of petroleum recovery and utilization. Extracellular polymers formed by moderately halophilic bacteria undoubtedly have significant advantages.
(5) 环保方面上的应用。现代工业污水中含有很多难以处理的化学物质如高盐离子和有毒有机物等,用传统生物方法常常收效甚微。而有些中度嗜盐菌由于其强大的适应能力及独特的生理生化特性,在很高盐浓度中就能够完成对甲醛、有机磷、芳烃如苯酚等有毒物质的降解且绿色环保,在处理环境污染方面日益受到人们关注。(5) Applications in environmental protection. Modern industrial wastewater contains many difficult-to-treat chemical substances such as high-salt ions and toxic organic substances, and traditional biological methods often have little effect. Due to their strong adaptability and unique physiological and biochemical characteristics, some moderately halophilic bacteria can degrade toxic substances such as formaldehyde, organic phosphorus, and aromatic hydrocarbons such as phenol in very high salt concentrations, and are environmentally friendly. Pollution is a growing concern.
(6) 其他方面的应用。除了以上方面的应用,中度嗜盐菌在其他很多方面依然表现出很好的应用前景。如抗生素等活性物质的生产,新型酶如限制性内切酶等的提取,以及乳化剂的合成等方面都有广泛的用途。(6) Other applications. In addition to the above applications, moderately halophilic bacteria still show good application prospects in many other aspects. Such as the production of active substances such as antibiotics, the extraction of new enzymes such as restriction endonucleases, and the synthesis of emulsifiers are widely used.
发明内容Contents of the invention
针对国内外有关嗜盐芽孢杆菌的研究现状,本发明提供一种新的嗜盐芽孢杆菌及其应用,所述的嗜盐芽孢杆菌碱性磷酸酶阴性、缬氨酸芳基酰胺酶阳性β-葡萄糖醛酸酶阴性,同时与该属所有其他菌株16S rDNA最高相似度分布在95.655%至96.348%(NCBI),这些特征明显区别于已公开报道的嗜盐芽孢杆菌有效种。Aiming at the current research status of halophilic bacillus at home and abroad, the present invention provides a new halophilic bacillus and its application. The halophilic bacillus is negative for alkaline phosphatase and positive for valine arylamidase Glucuronidase is negative, and the highest 16S rDNA similarity with all other strains of this genus is distributed between 95.655% and 96.348% (NCBI). These characteristics are obviously different from the effective species of Bacillus halophilus that have been reported publicly.
本发明具体提供一种莎车芽孢杆菌(Bacillus shacheensis )。The present invention specifically provides a Bacillus shacheensis .
本发明通过以不同的温度、pH值、盐浓度和培养基为富集条件,从新疆莎车盐湖中取样,分离纯化培养到多株菌,经过多级筛选确定一株嗜盐芽孢杆菌(Bacillus shacheensis HNA-14),命名为莎车芽孢杆菌该菌株已于申请日前保藏于布达佩斯条约微生物国际保藏单位:韩国典型菌种保藏单位(KCTC),保藏时间为2013年3月26日,保藏号是KCTC 33145,KCTC地址为韩国大田市儒城区韩国生物科学和技术研究所,邮编是305-806,经微生物多相分类鉴定为莎车芽孢杆菌(Bacillus shacheensis )。该菌为好氧菌,革兰氏阳性,运动性,呈短杆状,大小范围为0.5–0.8×1.0–1.5 μm,端生孢子,孢子囊些微肿胀,菌落呈黄色,形状呈圆形规则,边缘光滑。NaCl耐受范围为3%-20%, pH生长范围为6.5-10.0,温度生长范围为5-40℃。氧化酶和过氧化氢酶阳性,不具有硝酸还原能力,可以水解淀粉和明胶,不能水解吐温-80和纤维素。其生长过程中不产生H2S和吲哚,M.R.和V.P.实验阴性。能利用碳源:D-麦芽糖、D-海藻糖、D-纤维二糖、龙胆二糖、蔗糖、D-松二糖、水苏糖、四唑紫、D-蜜三糖、α-D-乳糖、β-甲基-D-葡萄糖苷、D-水杨苷、D-山梨醇、D-阿拉伯醇、肌醇、果胶、D-葡萄糖酸、D-葡萄糖醛酸、葡罗酰胺、L-乳酸、D-苹果酸、L-苹果酸、氧化锂、吐温-40、α-羟基丁酸、α-羟基丁酸、β-羟基丁酸、乙酰乙酸、丙酸、醋酸、丁酸钠和溴酸钠;不能利用碳源:糊精、万古霉素、四唑蓝、D-蜜二糖、N-乙酰-D-氨基葡萄糖、N-乙酰-β-D-甘露糖胺、N-乙酰-D-半乳糖胺、N-乙酰-神经氨酸、α-D-葡萄糖、D-甘露糖、D-果糖、D-半乳糖、3-甲基-葡萄糖、D-岩藻糖、L-岩藻糖、L-鼠李糖肌苷、1%乳酸钠、梭链孢酸、D-丝氨酸、D-甘露醇、甘油、D-葡萄糖-6-磷酸、D-果糖-6-磷酸、D-天门冬氨酸、D-丝氨酸、醋竹桃霉素、利福霉素、二甲胺四环素、明胶、氨基乙酰-L-脯氨酸、L-丙氨酸、L-精氨酸、L-天门冬氨酸、L-左旋谷氨酸、L-组氨酸、L-焦谷氨酸、L-丝氨酸、林可霉素、盐酸胍、硫酸四癸钠、D-半乳糖醛酸L-半乳糖酸内酯、粘酸、奎尼酸、D-葡糖二酸、p-羟基-苯乙酸、丙酮酸甲酯、D-乳酸、甲酯、L-乳酸柠檬酸、α-氧代戊二酸、溴代丁二酸、萘啶酮酸、亚碲酸钾、γ-氨基丁酸、α-氧代丁酸、甲酸和氨曲南。细胞主要脂肪酸为anteiso-C15:0和iso-C15:0,主要醌类型为MK-7,细胞壁肽聚糖类型主要为内消旋二氨基庚二酸(meso-DAP),主要极性脂为双磷脂酰甘油(DPG),磷脂酰乙醇胺(PE),磷脂酰肌醇(PI)。DNA(G+C)含量为48.6 mol%。The present invention uses different temperature, pH value, salt concentration and culture medium as enrichment conditions, takes samples from Shache Salt Lake in Xinjiang, separates, purifies and cultures multiple strains of bacteria, and determines a strain of halophilic Bacillus ( Bacillus shacheensis HNA-14), named Bacillus shacheensis. The strain has been deposited in Budapest Treaty of Microorganisms International Depository Unit: Korean Collection of Type Cultures (KCTC) before the application date. The preservation time is March 26, 2013, and the preservation number is KCTC 33145, the address of KCTC is the Korea Institute of Bioscience and Technology, Yucheng District, Daejeon City, Korea, the postal code is 305-806, and it was identified as Bacillus shacheensis by multiphase classification of microorganisms. The bacteria is aerobic, Gram-positive, motile, short rod-shaped, with a size range of 0.5–0.8×1.0–1.5 μm, terminal spores, slightly swollen sporangia, yellow colonies, and regular round shapes , with smooth edges. The NaCl tolerance range is 3%-20%, the pH growth range is 6.5-10.0, and the temperature growth range is 5-40°C. Positive for oxidase and catalase, no nitrate reducing ability, can hydrolyze starch and gelatin, but cannot hydrolyze Tween-80 and cellulose. H2S and indole were not produced during its growth, and MR and VP tests were negative. Carbon sources available: D-maltose, D-trehalose, D-cellobiose, gentiobiose, sucrose, D-turanose, stachyose, tetrazolium violet, D-raffinose, α-D - Lactose, β-methyl-D-glucoside, D-salicin, D-sorbitol, D-arabinol, inositol, pectin, D-gluconic acid, D-glucuronic acid, glucuronamide, L-lactic acid, D-malic acid, L-malic acid, lithium oxide, Tween-40, alpha-hydroxybutyric acid, alpha-hydroxybutyric acid, beta-hydroxybutyric acid, acetoacetic acid, propionic acid, acetic acid, butyric acid Sodium and sodium bromate; unavailable carbon sources: dextrin, vancomycin, tetrazolium blue, D-melibiose, N-acetyl-D-glucosamine, N-acetyl-β-D-mannosamine, N -Acetyl-D-galactosamine, N-acetyl-neuraminic acid, α-D-glucose, D-mannose, D-fructose, D-galactose, 3-methyl-glucose, D-fucose, L-fucose, L-rhamnosine, 1% sodium lactate, fusidic acid, D-serine, D-mannitol, glycerin, D-glucose-6-phosphate, D-fructose-6-phosphate, D-Aspartic Acid, D-Serine, Troleandomycin, Rifamycin, Minocycline, Gelatin, Aminoacetyl-L-Proline, L-Alanine, L-Arginine, L-Aspartic Acid, L-L-Glutamic Acid, L-Histidine, L-Pyroglutamic Acid, L-Serine, Lincomycin, Guanidine Hydrochloride, Tetradecyl Sodium Sulfate, D-Galacturonic Acid L-galactonolactone, mucic acid, quinic acid, D-glucaric acid, p-hydroxy-phenylacetic acid, methyl pyruvate, D-lactic acid, methyl ester, L-lactic citric acid, alpha-oxo Glutaric acid, bromosuccinic acid, nalidixic acid, potassium tellurite, gamma-aminobutyric acid, alpha-oxobutyric acid, formic acid, and aztreonam. The main fatty acids in cells are anteiso-C15:0 and iso-C15:0, the main quinone type is MK-7, the main type of cell wall peptidoglycan is meso-diaminopimelic acid (meso-DAP), and the main polar lipids are Diphosphatidylglycerol (DPG), Phosphatidylethanolamine (PE), Phosphatidylinositol (PI). The DNA (G+C) content was 48.6 mol%.
该莎车芽孢杆菌Bacillus shacheensis HNA-14的酶学特性采用API ZYM系统检测,碳源利用情况采用Biolog全自动细菌鉴定系统,主要脂肪酸类型及含量参考《放线菌系统学》,并采用气质联用分析,极性脂类型分析参考《放线菌系统学》,呼吸醌组分以及G+Cmol% 均采用高效液相(HPLC)来分析。The enzymatic properties of the Bacillus shacheensis HNA-14 were detected by the API ZYM system, and the carbon source utilization was detected by the Biolog automatic bacterial identification system. For analysis, polar lipid type analysis refers to Actinomycetes Systematics, respiratory quinone components and G+Cmol% are analyzed by high performance liquid phase (HPLC).
本发明通过提取总得DNA、16S rDNA基因的扩增和测序,根据测序结果,在NCBI上用Blast进行比对分析,整理出相似度较高的相关菌株的16S rDNA序列,Clustal X1.83进行多序列匹配排列后,通过MEGA5.0程序中的邻接法(Neighbor-Joining)和最大似然法(Maximum-Likelihood)构建系统发育树。In the present invention, by extracting the total DNA, amplification and sequencing of 16S rDNA genes, according to the sequencing results, Blast is used for comparison and analysis on NCBI, and the 16S rDNA sequences of related strains with high similarity are sorted out, and Clustal X1.83 is used for multiple After the sequences were matched and arranged, a phylogenetic tree was constructed by the Neighbor-Joining and Maximum-Likelihood methods in the program MEGA5.0.
经测定莎车芽孢杆菌Bacillus shacheensis HNA-14的16S rRNA序列长1570bp,如下:TCAGAGTTTGATCCTGGCTCAGGACGAACGCTGGCGGCATGCCTAATACATGCAAGTCGAGCGAACCAAAGGGAGCTTGCTCCCGGAGGTTAGCGGCGGACGGGTGAGTACCACGTGGGCAACCTGCCCCATGGACAGGGATAACTCCGGGAAACCGGAGCTAATACCGGATAAGACCGACCTTCGCCTGGAGGTTGGTTGAAAGATGGCCTTTAAGGCTATCACCAAGGGATGGGCCCGCGGCGCATTAGCTAGTTGGTAAGGTAAAGGCTTACCAAGGCGACGATGCGTAGCCGACCTGAGAGGGTGATCGGCCACACTGGGACTGAGACACGGCCCAGACTCCTACGGGAGGCAGCAGTAGGGAATCTTCCGCAATGGACGAAAGTCTGACGGAGCAATGCCGCGTGAGTGAGGAAGGCCTTCGGGTCGTAAAGCTCTGTTGCGAGGGAAGAAGCAAGTACCGGTGGATAACGCCGGTACCCTGACGGTACCTCGCCAGAAAGCCACGGCTAACTACGTGCCAGCAGCCGCGGTAATACGTAGGTGGCAAGCGTTGTCCGGAATTATTGGGCGTAAAGCGCGCGCAGGCGGCTTCTTAAGTCTGATGTGAAATCTTGGGGCTCAACCCCGAGCGGCCATTGGAAACTGGGGAGCTTGAGTGCAGAAGAGGAGAGTGGAATTCCACGTGTAGCGGTGAAATGCGTAGAGATGTGGAGGAACACCAGTGGCGAAGGCGACTCTCTGGTCTGTAACTGACGTTGAGGCGCGAAAGCGTGGGGAGCAAACAGGATTAGATACCCTGGTAGTCCACGCCGTAAACGATGAGTGCTAGGTGTTAGGGGTTTCGATGCCCGTAGTGCCGAAGTCAACACATTAAGCACTCCGCCTGGGGAGTACGGCCGCAAGGCTGAAACTCAAAGGAATTGACGGGGACCCGCACAAGCAGTGGAGCATGTGGTTTAATTCGATGCAACGCGAAGAACCTTACCAGGTCTTGACATCCTTTGACCACCCTGGAGACAGGGCTTCCCCTTCGGGGGCAAAGTGACAGGTGGTGCATGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCCCGCAACGAGCGCAACCCTTAATCTTAGTTGCCAGCATTGAGTTGGGCACTCTAAGGTGACTGCCGGTGACAAACCGGAGGAAGGTGGGGACGACGTCAAATCATCATGCCCCTTATGACCTGGGCTACACACGTGCTACAATGGATGGTACAACGGGTAGCGAAGCCGTGAGGTGAAGCCAATCCCAGAAAGCCATTCTCAGTTCGGATTGCAGGCTGCAACTCGCCTGCATGAAGCCGGAATTGCTAGTAATCGCGGATCAGCATGCCGCGGTGAATACGTTCCCGGGTCTTGTACACACCGCCCGTCACACCACGAGAGTTTGTAACACCCGAAGTCGGTGAGGTAACCTTTGGAGCCAGCCGCCTAAGGTGGGACAGATGATTGGGGTGAAGTCGTAACAAGGTAGCCGTATCGGAAGGTGCGGCTGGATCACCTCCTTAAGCTTGGTACCCGGGAATCTCTAIt has been determined that the 16S rRNA sequence of Bacillus shacheensis HNA-14 is 1570bp long, as follows:
从基于16S rDNA基因构建的系统发育树可以明显地看出莎车芽孢杆菌Bacillus shacheensis HNA-14与三株芽孢杆菌属的模式菌株聚为一支,与最亲近的三个模式菌株Bacillus clausii KSM-K16T、Bacillus clausii DSM 8716T、Bacillus rhizosphaeraeSC-N012T的相似度分别为96.348%、95.951%和95.883%,均低于常用来划定新种的相似度阈值97%。基于对莎车芽孢杆菌Bacillus shacheensis HNA-14的表型、生理生化、基因型的分析,初步确定莎车芽孢杆菌Bacillus shacheensis HNA-14为芽孢杆菌属的一个新种。From the phylogenetic tree constructed based on the 16S rDNA gene, it can be clearly seen that Bacillus shacheensis HNA-14 and the three type strains of the genus Bacillus are clustered together, and the three closest type strains Bacillus clausii KSM- The similarities of K16 T , Bacillus clausii DSM 8716 T , and Bacillus rhizosphaerae SC-N012 T were 96.348%, 95.951% and 95.883%, respectively, all of which were lower than the similarity threshold of 97%, which is commonly used to delineate new species. Based on the analysis of phenotype, physiology, biochemistry and genotype of Bacillus shacheensis HNA-14, Bacillus shacheensis HNA-14 was preliminarily identified as a new species of Bacillus.
基于新疆莎车嗜盐菌(Bacillusshacheensis)能有效分解淀粉,具有Esterase(C4)、Esterase lipase(C8)、Valinearylamidase、Acid phosphatase和Naphthol-AS-B1-phosphohydrolase酶活性,有较高的盐浓度适应性,能使明胶液化和牛奶胨化等特性,本发明提供的莎车芽孢杆菌Bacillus shacheensis HNA-14能广泛的应用于食品工业、酶制剂和基因工程等领域。Based on the fact that Bacillus shacheensis can effectively decompose starch, it has enzyme activities of Esterase (C4), Esterase lipase (C8), Valinearylamidase, Acid phosphatase and Naphthol-AS-B1-phosphohydrolase, and has high adaptability to salt concentration , can make gelatin liquefaction and milk peptonization, etc., the Bacillus shacheensis HNA-14 provided by the invention can be widely used in the fields of food industry, enzyme preparation and genetic engineering.
将该菌种的种子液以5%的接种量接种到15%盐浓度TSB培养基中,37℃、200rpm条件下发酵培养3天,12000rpm离心去除杂质和菌体,1℃下65%硫酸铵盐析,12000rpm离心后收集沉淀,1℃25mM Tris-HCl重新溶解后,在含有5mM Ca2+、mM Tris-HCl中1℃条件下透析10小时,结束后12000rpm离心去杂质,上清液即为淀粉酶。The seed liquid of the strain was inoculated into 15% salt concentration TSB medium with 5% inoculum amount, fermented and cultured at 37°C and 200rpm for 3 days, centrifuged at 12000rpm to remove impurities and bacteria, and 65% ammonium sulfate at 1°C Salt out, collect the precipitate after centrifugation at 12,000rpm, redissolve in 25mM Tris-HCl at 1°C, dialyze in 5mM Ca 2+ and mM Tris-HCl at 1°C for 10 hours, centrifuge at 12,000rpm to remove impurities, and the supernatant is ready for amylase.
通过实施本发明具体的技术指标,可达到以下效果。By implementing the specific technical indicators of the present invention, the following effects can be achieved.
本发明的莎车芽孢杆菌Bacillus shacheensis 能用于高盐浓度条件下发酵生产淀粉酶、明胶酶,同时能应用在Esterase(C4)、Esterase lipase(C8)、Valinearylamidase、Acid phosphatase和Naphthol-AS-B1-phosphohydrolase相关领域。The Bacillus shacheensis of the present invention can be used to ferment and produce amylase and gelatinase under high salt concentration conditions, and can also be used in Esterase (C 4 ), Esterase lipase (C 8 ), Valinearylamidase, Acid phosphatase and Naphthol-AS -B1-phosphohydrolase-related fields.
附图说明:图1是 扫描电子显微镜10000倍下观察到的菌株HNA-14的形貌。图2是采用邻接法构建菌株HNA-14与相关分类的16S rRNA基因序列系统发育树;Bar表示每单位核苷酸替换数为0.01 。Description of the drawings: Figure 1 is the morphology of bacterial strain HNA-14 observed under a scanning electron microscope at 10,000 times. Figure 2 is the 16S rRNA gene sequence phylogenetic tree of strain HNA-14 and related classifications constructed by the neighbor-joining method; Bar indicates that the number of nucleotide substitutions per unit is 0.01.
具体实施方式detailed description
实施例一:莎车芽孢杆菌的筛选与分离Example 1: Screening and isolation of Bacillus shachei
样品采集与菌株筛选分离Sample collection and strain screening and isolation
样品采集于新疆维吾尔族自治区莎车县。样品来自多个区域,分布于东经76°1′57″至77°46′30″、北纬37°27′30″至39°15″之间。用无菌玻璃瓶收取距表层5-10cm土壤,经风干,研磨,过筛,置于4℃保存,用于后续分离。筛选培养基选用苯酚富集培养基(PT),腐殖酸富集培养基(HVA),钼酸钠富集培养基(HNA)和高盐富集培养基(YCSS),纯化培养基选用胰蛋白胨大豆肉汤培养基(TSB+10% NaCl),通过接种不同的富集培养基对菌株进行筛选。将1g土样加入装有25ml液体培养基的摇瓶中,在28℃下振荡培养7天。然后用移液枪吸取富集液,作10倍梯度稀释,取200μl 10-1~10-4倍数稀释液分别涂布到对应培养基平板上,置于28℃下继续培养一周。观察生长状况与形态特征,将长出的菌落转接至TSB固体培养基,经多次划线,再挑取单菌落转接至TSB斜面培养基,置于4℃作短期保藏。同时取新鲜菌液混合25%浓度甘油,置于-80℃作长期保藏。(所有培养基配方见下表)The samples were collected in Shache County, Xinjiang Uygur Autonomous Region. The samples come from multiple areas, distributed between 76°1'57" to 77°46'30" east longitude and 37°27'30" to 39°15" north latitude. The soil 5-10cm from the surface was collected in a sterile glass bottle, air-dried, ground, sieved, and stored at 4°C for subsequent separation. The screening medium was phenol-enriched medium (PT), humic acid-enriched medium (HVA), sodium molybdate-enriched medium (HNA) and high-salt-enriched medium (YCSS), and the purification medium was pancreatic Peptone Soy Broth (TSB+10% NaCl), strains were screened by inoculating different enrichment media. Add 1 g of the soil sample into a shaker flask filled with 25 ml of liquid medium, and culture it with shaking at 28°C for 7 days. Then use a pipette gun to draw the enriched solution, make a 10-fold serial dilution, take 200 μl of 10 -1 ~ 10 -4 multiple dilutions and spread them on the corresponding medium plates respectively, and place them at 28°C for a further week of cultivation. Observe the growth status and morphological characteristics, transfer the grown colony to TSB solid medium, and then pick a single colony and transfer it to TSB slant medium after multiple streaks, and store it at 4°C for short-term storage. At the same time, take fresh bacterial liquid mixed with 25% glycerol and store at -80°C for long-term preservation. (All media formulations are listed in the table below)
苯酚富集培养基(PT):酪蛋白胨7.5g,氯化钠100g,酵母浸出物10g,苯酚690μl ,MS混合液1 unit,无菌水1000ml ,pH8.2-8.5。Phenol enriched medium (PT): 7.5g casein peptone, 100g sodium chloride, 10g yeast extract, 690μl phenol, 1 unit of MS mixed solution, 1000ml sterile water, pH8.2-8.5.
腐殖酸富集培养基(HVA) :腐殖酸1g,氯化钠150g ,MS混合液1 unit,无菌水1000ml ,pH8.2-8.5。Humic acid-enriched medium (HVA): 1g of humic acid, 150g of sodium chloride, 1 unit of MS mixed solution, 1000ml of sterile water, pH8.2-8.5.
钼酸钠富集培养基(HNA):酪蛋白胨7.5g,氯化钠150g,酵母浸出物10g ,MS混合液1 unit,无菌水1000ml ,pH8.2-8.5。Sodium molybdate enriched medium (HNA): 7.5g of casein peptone, 150g of sodium chloride, 10g of yeast extract, 1 unit of MS mixed solution, 1000ml of sterile water, pH8.2-8.5.
高盐富集培养基(YCSS):酪蛋白胨7.5g,氯化钠250g,酵母浸出物10g, MS混合液1unit,无菌水1000ml ,pH8.2-8.5。High-salt enrichment medium (YCSS): 7.5g casein peptone, 250g sodium chloride, 10g yeast extract, 1unit MS mixture, 1000ml sterile water, pH8.2-8.5.
MS混合液:浓度为0.05g/L相容性物质(甜菜碱,脯氨酸,甘氨酸,D-山梨醇,谷氨酸盐)混合液1.5ml;浓度为0.05g/L氨基酸(天冬氨酸,组氨酸,赖氨酸,蛋氨酸,缬氨酸,亮氨酸,酪氨酸,谷氨酸)混合液15ml;浓度为0.025mg/L维生素(VB1,VB2,VB12,VB6,VH,VM,VPP)混合液0.25ml。MS mixed solution: the concentration is 0.05g/L compatible substance (betaine, proline, glycine, D-sorbitol, glutamate) mixed solution 1.5ml; the concentration is 0.05g/L amino acid (aspartic acid) acid, histidine, lysine, methionine, valine, leucine, tyrosine, glutamic acid) mixture 15ml; the concentration is 0.025mg/L vitamins (VB1, VB2, VB12, VB6, VH, VM, VPP) mixed solution 0.25ml.
胰蛋白胨大豆肉汤培养基(TSB+10% NaCl):胰蛋白胨15g,大豆蛋白胨5g ,NaCl100g,琼脂粉18g,蒸馏水1000ml, pH8.0-8.2。Tryptone soybean broth medium (TSB+10% NaCl): tryptone 15g, soybean peptone 5g, NaCl 100g, agar powder 18g, distilled water 1000ml, pH8.0-8.2.
菌种描述:Description of strains:
本发明所述的莎车芽孢杆菌为好氧菌,革兰氏阳性,运动性,呈短杆状,大小范围为0.5–0.8×1.0–1.5 μm,端生孢子,孢子囊些微肿胀,菌落呈黄色,形状呈圆形规则,边缘光滑。NaCl耐受范围为3%-20%(最佳盐浓度为7%-15%), pH生长范围为6.5-10.0(最佳pH范围为7.5-8.0),温度生长范围为5-40℃(最佳生长温度为25-30℃)。氧化酶和过氧化氢酶阳性,不具有硝酸还原能力,可以水解淀粉和明胶,不能水解吐温-80和纤维素。其生长过程中不产生H2S和吲哚,M.R.和V.P.实验阴性。细胞主要脂肪酸为anteiso-C15:0和iso-C15:0,主要醌类型为MK-7,细胞壁肽聚糖类型主要为内消旋二氨基庚二酸(meso-DAP),主要极性脂为双磷脂酰甘油(DPG),磷脂酰乙醇胺(PE),磷脂酰肌醇(PI)。The Bacillus shachei described in the present invention is an aerobic bacterium, Gram-positive, motile, short-rod-shaped, with a size range of 0.5-0.8×1.0-1.5 μm, terminal spores, slightly swollen sporangia, and colonies in the form of Yellow in color, round and regular in shape with smooth edges. The NaCl tolerance range is 3%-20% (the optimal salt concentration is 7%-15%), the pH growth range is 6.5-10.0 (the optimal pH range is 7.5-8.0), and the temperature growth range is 5-40°C ( The optimum growth temperature is 25-30°C). Positive for oxidase and catalase, no nitrate reducing ability, can hydrolyze starch and gelatin, but cannot hydrolyze Tween-80 and cellulose. It does not produce H2S and indole during its growth, and M.R. and V.P. tests are negative. The main fatty acids in cells are anteiso-C15:0 and iso-C15:0, the main quinone type is MK-7, the main type of cell wall peptidoglycan is meso-diaminopimelic acid (meso-DAP), and the main polar lipids are Diphosphatidylglycerol (DPG), Phosphatidylethanolamine (PE), Phosphatidylinositol (PI).
实施例二:莎车芽孢杆菌HNA-14表型特征Example 2: Phenotypic characteristics of Bacillus shachei HNA-14
通过BIOLOG GENMicroStation自动微生物鉴定系统,得到HNA-14碳源利用情况如下表所示。其中HNA-14的参比菌株为Bacillus clausii DSM 8716T by BIOLOG GEN The MicroStation automatic microbial identification system obtained the carbon source utilization of HNA-14 as shown in the table below. The reference strain of HNA-14 is Bacillus clausii DSM 8716 T
能利用碳源:D-麦芽糖、D-海藻糖、D-纤维二糖、龙胆二糖、蔗糖、D-松二糖、水苏糖、四唑紫、D-蜜三糖、α-D-乳糖、β-甲基-D-葡萄糖苷、D-水杨苷、D-山梨醇、D-阿拉伯醇、肌醇、果胶、D-葡萄糖酸、D-葡萄糖醛酸、葡罗酰胺、L-乳酸、D-苹果酸、L-苹果酸、氧化锂、吐温-40、α-羟基丁酸、α-羟基丁酸、β-羟基丁酸、乙酰乙酸、丙酸、醋酸、丁酸钠和溴酸钠;不能利用碳源:糊精、万古霉素、四唑蓝、D-蜜二糖、N-乙酰-D-氨基葡萄糖、N-乙酰-β-D-甘露糖胺、N-乙酰-D-半乳糖胺、N-乙酰-神经氨酸、α-D-葡萄糖、D-甘露糖、D-果糖、D-半乳糖、3-甲基-葡萄糖、D-岩藻糖、L-岩藻糖、L-鼠李糖肌苷、1%乳酸钠、梭链孢酸、D-丝氨酸、D-甘露醇、甘油、D-葡萄糖-6-磷酸、D-果糖-6-磷酸、D-天门冬氨酸、D-丝氨酸、醋竹桃霉素、利福霉素、二甲胺四环素、明胶、氨基乙酰-L-脯氨酸、L-丙氨酸、L-精氨酸、L-天门冬氨酸、L-左旋谷氨酸、L-组氨酸、L-焦谷氨酸、L-丝氨酸、林可霉素、盐酸胍、硫酸四癸钠、D-半乳糖醛酸L-半乳糖酸内酯、粘酸、奎尼酸、D-葡糖二酸、p-羟基-苯乙酸、丙酮酸甲酯、D-乳酸、甲酯、L-乳酸柠檬酸、α-氧代戊二酸、溴代丁二酸、萘啶酮酸、亚碲酸钾、γ-氨基丁酸、α-氧代丁酸、甲酸和氨曲南。Carbon sources available: D-maltose, D-trehalose, D-cellobiose, gentiobiose, sucrose, D-turanose, stachyose, tetrazolium violet, D-raffinose, α-D - Lactose, β-methyl-D-glucoside, D-salicin, D-sorbitol, D-arabinol, inositol, pectin, D-gluconic acid, D-glucuronic acid, glucuronamide, L-lactic acid, D-malic acid, L-malic acid, lithium oxide, Tween-40, alpha-hydroxybutyric acid, alpha-hydroxybutyric acid, beta-hydroxybutyric acid, acetoacetic acid, propionic acid, acetic acid, butyric acid Sodium and sodium bromate; unavailable carbon sources: dextrin, vancomycin, tetrazolium blue, D-melibiose, N-acetyl-D-glucosamine, N-acetyl-β-D-mannosamine, N -Acetyl-D-galactosamine, N-acetyl-neuraminic acid, α-D-glucose, D-mannose, D-fructose, D-galactose, 3-methyl-glucose, D-fucose, L-fucose, L-rhamnosine, 1% sodium lactate, fusidic acid, D-serine, D-mannitol, glycerin, D-glucose-6-phosphate, D-fructose-6-phosphate, D-Aspartic Acid, D-Serine, Troleandomycin, Rifamycin, Minocycline, Gelatin, Aminoacetyl-L-Proline, L-Alanine, L-Arginine, L-Aspartic Acid, L-L-Glutamic Acid, L-Histidine, L-Pyroglutamic Acid, L-Serine, Lincomycin, Guanidine Hydrochloride, Tetradecyl Sodium Sulfate, D-Galacturonic Acid L-galactonolactone, mucic acid, quinic acid, D-glucaric acid, p-hydroxy-phenylacetic acid, methyl pyruvate, D-lactic acid, methyl ester, L-lactic citric acid, alpha-oxo Glutaric acid, bromosuccinic acid, nalidixic acid, potassium tellurite, gamma-aminobutyric acid, alpha-oxobutyric acid, formic acid, and aztreonam.
实施例三:莎车芽孢杆菌HNA-14基因组的提取以及16S rDNA测序Example 3: Extraction of Bacillus shachei HNA-14 genome and 16S rDNA sequencing
采用SDS法提取细菌总DNA,通过PCR法扩增菌株16S rRNA基因序列,DNA测序由上海生工生物工程技术服务有限公司完成。到GenBank(http://www.ncbi.nlm.nih.gov/)数据库将各菌株测得的16S rRNA基因部分序列提交注册获得序列号。再在NCBI(NationalCenter for Biotechnology Information)上进行BLAST比对,找到亲缘关系最近的菌株。通过BioEdit将亲缘性最近的相应菌株进行序列比对,然后在软件MEGA 5.0上分别使用Neighbor-Joinin(N-J)法,最大似然法(ML法)构建系统进化树,进化树bootstrap为1000。PCR相应引物、反应体系、条件如下:PCR引物:PA8: 5'-CCGTCGACGAGCTCAGAGTTTGATCCTGGCTCAG-3',PB1: 5'-CCCGGGTACCAAGCTTAAGGAGGTGATCCAGCCGCA-3';反应体系(25μl体系):Mg2+2.5μl,PA8 2.5μl,PB1 2.5μl,dNTP 0.75μl,H2O 14μl,Taq酶0.25μl,反应条件95℃预变性5min,94℃变性45s,50℃退火45s,延伸1min,重复35个循环,72℃保温10min。构建的进化树见图2。The total bacterial DNA was extracted by SDS method, the 16S rRNA gene sequence of the strain was amplified by PCR method, and the DNA sequencing was completed by Shanghai Sangon Bioengineering Technology Service Co., Ltd. Go to the GenBank (http://www.ncbi.nlm.nih.gov/) database to submit the partial sequence of the 16S rRNA gene measured by each strain for registration to obtain the sequence number. Then perform BLAST comparison on NCBI (National Center for Biotechnology Information) to find the strain with the closest relationship. The corresponding strains with the closest relatives were compared by BioEdit, and then the Neighbor-Joinin (NJ) method and the maximum likelihood method (ML method) were used to construct a phylogenetic tree on the software MEGA 5.0, and the bootstrap of the phylogenetic tree was 1000. The corresponding PCR primers, reaction system, and conditions are as follows: PCR primer: PA 8 : 5'-CCGTCGACGAGCTCAGAGTTTGATCCTGGCTCAG-3', PB 1 : 5'-CCCGGGTACCAAGCTTAAGGAGGTGATCCAGCCGCA-3'; reaction system (25μl system): Mg 2+ 2.5μl, PA 8 2.5 μl, PB 1 2.5 μl, dNTP 0.75 μl, H 2 O 14 μl, Taq enzyme 0.25 μl, reaction conditions 95°C pre-denaturation for 5 minutes, 94°C denaturation for 45 seconds, 50°C annealing for 45 seconds, extension for 1 minute, repeated 35 cycles, 72°C Keep warm for 10 minutes. The constructed phylogenetic tree is shown in Figure 2.
实施例四:莎车芽孢杆菌HNA-14的应用Embodiment 4: the application of Bacillus shachei HNA-14
用试管配制明胶液化培养基,121℃灭菌20min,将菌株穿刺接种,在30℃恒温箱中静置培养30天,分别在5,10,20,30天观察记录明胶液化程度。观察前将试管冷却20-30min或用自来水冲洗30min,可以更清晰的观察到液化程度。结果分析莎车芽孢杆菌HNA-14可使明胶液化。Prepare gelatin liquefaction medium in a test tube, sterilize at 121°C for 20 minutes, inoculate the strain by puncture, and culture it in a 30°C incubator for 30 days, observe and record the degree of gelatin liquefaction at 5, 10, 20, and 30 days respectively. Cool the test tube for 20-30 minutes or rinse it with tap water for 30 minutes before observation, so that the degree of liquefaction can be observed more clearly. Results Analysis Bacillus sacchari HNA-14 can liquefy gelatin.
实施例五:莎车芽孢杆菌HNA-14的应用Embodiment five: the application of Bacillus shachei HNA-14
用试管配制牛奶凝固与胨化培养基,煮沸30min,然后置于高速离心机中3000r/min离心30min,去除上清液,112℃,间歇灭菌30min 2-3次。接种待测菌株,在30℃恒温箱中静置培养30天,分别在5,10.20,30天观察记录牛奶凝固与胨化程度。结果分析,莎车芽孢杆菌HNA-14使牛奶出现凝块即为凝固,凝固后凝块水解为液体,证明其可以使牛奶胨化。Prepare milk coagulation and peptonization medium in a test tube, boil for 30 minutes, then place in a high-speed centrifuge and centrifuge at 3000r/min for 30 minutes, remove the supernatant, and sterilize intermittently for 30 minutes at 112°C 2-3 times. Inoculate the strain to be tested, and culture it statically in a 30°C incubator for 30 days, observe and record the degree of milk coagulation and peptonization at 5, 10, 20, and 30 days respectively. According to the analysis of the results, Bacillus shachei HNA-14 coagulates the milk when it coagulates. After coagulation, the coagulation is hydrolyzed into liquid, which proves that it can peptonize milk.
实施例六:莎车芽孢杆菌HNA-14的应用Embodiment 6: the application of Bacillus shachei HNA-14
配制淀粉水解平板培养基,121℃下,灭菌20min,用点接法接种待测菌株,接种直径不宜超过5mm;在30℃恒温箱中静置培养48h,观察生长情况,待生长良好时,向菌落周围滴加碘液进行检测,结果分析莎车芽孢杆菌HNA-14周围出现透明晕圈且不变色,证明其有水解淀粉的能力。Prepare the starch hydrolysis plate medium, sterilize at 121°C for 20 minutes, inoculate the strain to be tested by the spot method, and the inoculation diameter should not exceed 5mm; keep it in a constant temperature box at 30°C for 48 hours, observe the growth situation, and when the growth is good, Iodine solution was added dropwise around the colony for detection, and the results showed that a transparent halo appeared around Bacillus shachei HNA-14 and did not change color, which proved that it had the ability to hydrolyze starch.
TCAGAGTTTGATCCTGGCTCAGGACGAACGCTGGCGGCATGCCTAATACATGCAAGTCGAGCGAACCAAAGGGAGCTTGCTCCCGGAGGTTAGCGGCGGACGGGTGAGTACCACGTGGGCAACCTGCCCCATGGACAGGGATAACTCCGGGAAACCGGAGCTAATACCGGATAAGACCGACCTTCGCCTGGAGGTTGGTTGAAAGATGGCCTTTAAGGCTATCACCAAGGGATGGGCCCGCGGCGCATTAGCTAGTTGGTAAGGTAAAGGCTTACCAAGGCGACGATGCGTAGCCGACCTGAGAGGGTGATCGGCCACACTGGGACTGAGACACGGCCCAGACTCCTACGGGAGGCAGCAGTAGGGAATCTTCCGCAATGGACGAAAGTCTGACGGAGCAATGCCGCGTGAGTGAGGAAGGCCTTCGGGTCGTAAAGCTCTGTTGCGAGGGAAGAAGCAAGTACCGGTGGATAACGCCGGTACCCTGACGGTACCTCGCCAGAAAGCCACGGCTAACTACGTGCCAGCAGCCGCGGTAATACGTAGGTGGCAAGCGTTGTCCGGAATTATTGGGCGTAAAGCGCGCGCAGGCGGCTTCTTAAGTCTGATGTGAAATCTTGGGGCTCAACCCCGAGCGGCCATTGGAAACTGGGGAGCTTGAGTGCAGAAGAGGAGAGTGGAATTCCACGTGTAGCGGTGAAATGCGTAGAGATGTGGAGGAACACCAGTGGCGAAGGCGACTCTCTGGTCTGTAACTGACGTTGAGGCGCGAAAGCGTGGGGAGCAAACAGGATTAGATACCCTGGTAGTCCACGCCGTAAACGATGAGTGCTAGGTGTTAGGGGTTTCGATGCCCGTAGTGCCGAAGTCAACACATTAAGCACTCCGCCTGGGGAGTACGGCCGCAAGGCTGAAACTCAAAGGAATTGACGGGGACCCGCACAAGCAGTGGAGCATGTGGTTTAATTCGATGCAACGCGAAGAACCTTACCAGGTCTTGACATCCTTTGACCACCCTGGAGACAGGGCTTCCCCTTCGGGGGCAAAGTGACAGGTGGTGCATGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCCCGCAACGAGCGCAACCCTTAATCTTAGTTGCCAGCATTGAGTTGGGCACTCTAAGGTGACTGCCGGTGACAAACCGGAGGAAGGTGGGGACGACGTCAAATCATCATGCCCCTTATGACCTGGGCTACACACGTGCTACAATGGATGGTACAACGGGTAGCGAAGCCGTGAGGTGAAGCCAATCCCAGAAAGCCATTCTCAGTTCGGATTGCAGGCTGCAACTCGCCTGCATGAAGCCGGAATTGCTAGTAATCGCGGATCAGCATGCCGCGGTGAATACGTTCCCGGGTCTTGTACACACCGCCCGTCACACCACGAGAGTTTGTAACACCCGAAGTCGGTGAGGTAACCTTTGGAGCCAGCCGCCTAAGGTGGGACAGATGATTGGGGTGAAGTCGTAACAAGGTAGCCGTATCGGAAGGTGCGGCTGGATCACCTCCTTAAGCTTGGTACCCGGGAATCTCTATCAGAGTTTGATCCTGGCTCAGGACGAACGCTGGCGGCATGCCTAATACATGCAAGTCGAGCGAACCAAAGGGAGCTTGCTCCCGGAGGTTAGCGGCGGACGGGTGAGTACCACGTGGGCAACCTGCCCCATGGACAGGGATAACTCCGGGAAACCGGAGCTAATACCGGATAAGACCGACCTTCGCCTGGAGGTTGGTTGAAAGATGGCCTTTAAGGCTATCACCAAGGGATGGGCCCGCGGCGCATTAGCTAGTTGGTAAGGTAAAGGCTTACCAAGGCGACGATGCGTAGCCGACCTGAGAGGGTGATCGGCCACACTGGGACTGAGACACGGCCCAGACTCCTACGGGAGGCAGCAGTAGGGAATCTTCCGCAATGGACGAAAGTCTGACGGAGCAATGCCGCGTGAGTGAGGAAGGCCTTCGGGTCGTAAAGCTCTGTTGCGAGGGAAGAAGCAAGTACCGGTGGATAACGCCGGTACCCTGACGGTACCTCGCCAGAAAGCCACGGCTAACTACGTGCCAGCAGCCGCGGTAATACGTAGGTGGCAAGCGTTGTCCGGAATTATTGGGCGTAAAGCGCGCGCAGGCGGCTTCTTAAGTCTGATGTGAAATCTTGGGGCTCAACCCCGAGCGGCCATTGGAAACTGGGGAGCTTGAGTGCAGAAGAGGAGAGTGGAATTCCACGTGTAGCGGTGAAATGCGTAGAGATGTGGAGGAACACCAGTGGCGAAGGCGACTCTCTGGTCTGTAACTGACGTTGAGGCGCGAAAGCGTGGGGAGCAAACAGGATTAGATACCCTGGTAGTCCACGCCGTAAACGATGAGTGCTAGGTGTTAGGGGTTTCGATGCCCGTAGTGCCGAAGTCAACACATTAAGCACTCCGCCTGGGGAGTACGGCCGCAAGGCTGAAACTCAAAGGAATTGACGGGGACCCGCACAAGCAGTGGAGCATGTGGTTTAATTCGATGCAACGCGAAGAACCTTACCAGGTCTTG ACATCCTTTGACCACCCTGGAGACAGGGCTTCCCCTTCGGGGGCAAAGTGACAGGTGGTGCATGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCCCGCAACGAGCGCAACCCTTAATCTTAGTTGCCAGCATTGAGTTGGGCACTCTAAGGTGACTGCCGGTGACAAACCGGAGGAAGGTGGGGACGACGTCAAATCATCATGCCCCTTATGACCTGGGCTACACACGTGCTACAATGGATGGTACAACGGGTAGCGAAGCCGTGAGGTGAAGCCAATCCCAGAAAGCCATTCTCAGTTCGGATTGCAGGCTGCAACTCGCCTGCATGAAGCCGGAATTGCTAGTAATCGCGGATCAGCATGCCGCGGTGAATACGTTCCCGGGTCTTGTACACACCGCCCGTCACACCACGAGAGTTTGTAACACCCGAAGTCGGTGAGGTAACCTTTGGAGCCAGCCGCCTAAGGTGGGACAGATGATTGGGGTGAAGTCGTAACAAGGTAGCCGTATCGGAAGGTGCGGCTGGATCACCTCCTTAAGCTTGGTACCCGGGAATCTCTA
Claims (2)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410160307.8A CN104232503B (en) | 2014-04-22 | 2014-04-22 | A strain of Bacillus shachei and its application |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410160307.8A CN104232503B (en) | 2014-04-22 | 2014-04-22 | A strain of Bacillus shachei and its application |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104232503A CN104232503A (en) | 2014-12-24 |
| CN104232503B true CN104232503B (en) | 2017-01-25 |
Family
ID=52221413
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410160307.8A Expired - Fee Related CN104232503B (en) | 2014-04-22 | 2014-04-22 | A strain of Bacillus shachei and its application |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104232503B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116179618B (en) * | 2022-12-15 | 2024-10-15 | 光明乳业股份有限公司 | Biosynthesis method of lactobionic acid |
| CN118064325B (en) * | 2024-03-19 | 2024-08-20 | 宁波大学 | A myxobacterium mesophilic with effect of promoting Porphyra haitanensis filamentous sporocyst branch formation |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102676424A (en) * | 2012-03-22 | 2012-09-19 | 中国石油天然气集团公司 | Obligate halophile for processing high-salt oily waste liquor in petroleum industry |
| WO2013026033A2 (en) * | 2011-08-18 | 2013-02-21 | Dupont Nutrition Biosciences Aps | Strains and methods useful for mycotoxins |
-
2014
- 2014-04-22 CN CN201410160307.8A patent/CN104232503B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013026033A2 (en) * | 2011-08-18 | 2013-02-21 | Dupont Nutrition Biosciences Aps | Strains and methods useful for mycotoxins |
| CN102676424A (en) * | 2012-03-22 | 2012-09-19 | 中国石油天然气集团公司 | Obligate halophile for processing high-salt oily waste liquor in petroleum industry |
Non-Patent Citations (3)
| Title |
|---|
| Biocontrol Activity of Bacillus amyloliquefaciens CNU114001 against Fungal Plant Diseases;Seung Hyun Ji等;《Mycobiology》;20131231;第41卷(第4期);第234-242页 * |
| GenBank:HQ453967.1;Liu等;《NCBI》;20101225;第1-2页 * |
| 一株耐盐芽孢杆菌的分离与鉴定;周钰钢等;《北京科技大学学报增刊》;20071231;第29卷(第2期);第221-222页 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN104232503A (en) | 2014-12-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Yadav et al. | Psychrotrophic microbiomes: molecular diversity and beneficial role in plant growth promotion and soil health | |
| Zhou et al. | Isolation and characterization of urethanase from Penicillium variabile and its application to reduce ethyl carbamate contamination in Chinese rice wine | |
| Lee et al. | Marinobacter xestospongiae sp. nov., isolated from the marine sponge Xestospongia testudinaria collected from the Red Sea | |
| Pathak et al. | Isolation and characterization of salt stable protease producing archaea from marine solar saltern of Mulund, Mumbai | |
| Alam et al. | Purification and characterisation of extracellular protease produced by Clostridium sp. from Schirmacher oasis, Antarctica | |
| KR101300191B1 (en) | Bacillus licheniformis strain having ablity of decomposing tyramine and histamine and uses thereof | |
| Sanjaya et al. | Effect of pH, temperature, and salt concentration on the growth of Bacillus subtilis T9-05 isolated from fish sauce | |
| Kim et al. | Diversity of cold-active protease-producing bacteria from arctic terrestrial and marine environments revealed by enrichment culture | |
| Kumar et al. | Purification and characterization of a small size protease fran1 Bacillus sp. APR-4 | |
| Cui et al. | Mucilaginibacter composti sp. nov., with ginsenoside converting activity, isolated from compost | |
| CN104232503B (en) | A strain of Bacillus shachei and its application | |
| Joung et al. | Flavobacterium aquariorum sp. nov., isolated from freshwater of the North Han River | |
| Lee et al. | Paenibacillus marinisediminis sp. nov., a bacterium isolated from marine sediment | |
| CN103952347B (en) | One strain moderate salt tolerant bacillus marinus and application thereof | |
| Joung et al. | Pedobacter aquicola sp. nov., isolated from freshwater | |
| Fıtrıanı et al. | Isolation, screening, partial purification and characterization of protease from halophilic bacteria isolated from Indonesian fermented food | |
| CN103966146B (en) | One strain reaches wooden bacillus marinus and application thereof | |
| CN107794235B (en) | A kind of aerobic denitrifying bacteria and its application | |
| Ahn et al. | Niabella terrae sp. nov. isolated from greenhouse soil | |
| Mo et al. | Pseudonocardia broussonetiae sp. nov., an endophytic actinomycete isolated from the roots of Broussonetia papyrifera | |
| Erdyneeva et al. | Aminopeptidase activity of haloalkalophilic bacteria of the genus Halomonas isolated from the soda-saline lakes in the Badain Jaran Desert | |
| Lee et al. | Maribacter litoralis sp. nov. a marine bacterium isolated from seashore | |
| Kuddus et al. | Purification and properties of cold-active metalloprotease from Curtobacterium luteum and effect of culture conditions on production | |
| CN110684692B (en) | A strain of Stenotrophomonas maltophilia 780 and its application | |
| Kim et al. | Kurthia ruminicola sp. nov., isolated from the rumen contents of a Holstein cow |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20170125 Termination date: 20170422 |